Pelthos Therapeutics Inc.

AMEX:PTHS

Biotechnology

Healthcare
$16.54 -1.28%

-$0.37 today

Market cap
$63.32M
Beta
3.13
P/E (TTM)
-0.7
EPS (TTM)
-$15.58
52W Low $16.50High $37.50

Volume 0.01M

Average 0.04M

Balance Sheet

Inspect the capital base behind the business.

Assets

$130.40M

FY 2025 · Annual

+9424.0% YoY

Liabilities

$91.52M

FY 2025 · Annual

+2141.3% YoY

Equity

$38.88M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents55.07K96.39K513.44K18.02M
Short-term Investments0000
Net Receivables0040.4K8.86M
Inventory00023.57M
Other Current Assets00750K419K
Total Current Assets55.07K96.39K1.37M52.7M
Property, Plant & Equipment (Net)00012.84M
Goodwill00024.68M
Intangible Assets00039.47M
Long-term Investments0000
Tax Assets0000
Other Non-current Assets000711K
Total Non-current Assets00077.7M
Total Assets55.07K96.39K1.37M130.4M
Account Payables2.99M4.62M1.9M2.99M
Short-term Debt540.43K1.27M2.19M635K
Tax Payables0000
Deferred Revenue000966K
Other Current Liabilities221.88K645.95K021.41M
Total Current Liabilities3.76M6.54M4.08M25.99M
Long-term Debt00031.44M
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)0001.28M
Other Non-current Liabilities00030.05M
Total Non-current Liabilities00065.52M
Total Liabilities3.76M6.54M4.08M91.52M
Common Stock1113916130
Retained Earnings(6.14M)(13.52M)(21.47M)(64.79M)
Accumulated OCI0000
Other Stockholders Equity0000
Minority Interest0000
Total Equity(3.71M)(6.44M)(2.71M)38.88M
Total Debt540.43K1.27M2.19M34.83M
Net Debt485.36K1.17M1.67M16.81M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$32.2M
Receivables$11.7M
Inventory$23.4M
Other Current$1.7M
Total Current Assets$69.1M
PP&E (Net)$12.5M
Goodwill$24.7M
Intangible Assets$38.4M
Other Non-current$711.0K
Total Non-current Assets$76.3M
Total Assets$145.4M

Analysis

Selected assets total $145.4M for Latest. The largest visible component is Intangible Assets at $38.4M, about 26.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportMay 28, 2026
4Statement of changes in beneficial ownershipMay 26, 2026
144Notice of proposed sale of securitiesMay 22, 2026
8-KCurrent reportMay 21, 2026
4Statement of changes in beneficial ownershipMay 18, 2026

How much cash does PTHS have?

Pelthos Therapeutics Inc. (PTHS) reported $18.02M in cash and equivalents in fiscal 2025.

How much debt does PTHS carry?

Pelthos Therapeutics Inc. (PTHS) reported $34.83M of total debt, with net debt of $16.80M.